Zkusit zdarma
Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.

AMLX
Cena:
$ 13.58
-0.35 (-2.51%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation

Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation

12:11 15-05-2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the ...

Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus

Amylyx Pharmaceuticals Eyes Phase 3 AVEXITIDE Readout as 2027 Launch Comes Into Focus

1:06 14-05-2026

Amylyx Pharmaceuticals NASDAQ: AMLX is preparing for a pivotal Phase 3 readout for AVEXITIDE, its le...

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Transcript

20:20 13-05-2026

Amylyx Pharmaceuticals, Inc. (AMLX) Presents at Bank of America Global Healthcare Conference 2026 Tr...

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript

17:01 07-05-2026

Amylyx Pharmaceuticals, Inc. (AMLX) Q1 2026 Earnings Call Transcript...

Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results

7:00 07-05-2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Reports First Quarter 2026 Finan...

Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch

Amylyx Pharmaceuticals Sets Up Q3 Phase 3 Avexitide Data Readout, Eyes Potential 2027 Launch

3:31 17-04-2026

Amylyx Pharmaceuticals (NASDAQ: AMLX) is entering what it described as a pivotal year for its lead p...

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

19:54 09-04-2026

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or ob...

Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference

9:00 08-04-2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals to Present at the 25th Annual Ne...

Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia

7:00 24-03-2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces Completion of Enrollme...

437,391 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by Ally Bridge Group NY LLC

437,391 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Purchased by Ally Bridge Group NY LLC

3:31 15-03-2026

Ally Bridge Group NY LLC acquired a new position in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) in t...

Amylyx Pharmaceuticals, Inc. $AMLX Shares Acquired by Alpha Wave Global LP

Amylyx Pharmaceuticals, Inc. $AMLX Shares Acquired by Alpha Wave Global LP

3:05 14-03-2026

Alpha Wave Global LP increased its position in Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) by 18.7% ...

Amylyx Pharmaceuticals Q4 Earnings Call Highlights

Amylyx Pharmaceuticals Q4 Earnings Call Highlights

1:32 05-03-2026

Amylyx Pharmaceuticals (NASDAQ: AMLX) executives told investors the company entered 2026 with a focu...

Amylyx: LUCIDITY Trial Sets Stage For Q3 Inflection Point

Amylyx: LUCIDITY Trial Sets Stage For Q3 Inflection Point

18:03 04-03-2026

Amylyx Pharmaceuticals (AMLX) is downgraded from 'Strong Buy' to 'Buy' following the discontinuation...

Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout

Amylyx Pharmaceuticals Says 2026 Could Be “Transformative” Ahead of Avexitide Phase 3 Readout

4:32 04-03-2026

Amylyx Pharmaceuticals (NASDAQ: AMLX) executives outlined a slate of milestones they expect to shape...

Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2025 Earnings Call Transcript

Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2025 Earnings Call Transcript

16:32 03-03-2026

Amylyx Pharmaceuticals, Inc. (AMLX) Q4 2025 Earnings Call Transcript...

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results

7:00 03-03-2026

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx” or the ...

Financial Survey: Amylyx Pharmaceuticals (NASDAQ:AMLX) vs. Theravance Biopharma (NASDAQ:TBPH)

Financial Survey: Amylyx Pharmaceuticals (NASDAQ:AMLX) vs. Theravance Biopharma (NASDAQ:TBPH)

1:15 10-02-2026

Theravance Biopharma (NASDAQ: TBPH - Get Free Report) and Amylyx Pharmaceuticals (NASDAQ: AMLX - Get...

Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million

Amylyx Pharmaceuticals Co-Chief Executive Sells AMLX 138K Shares for $1.9 Million

23:49 31-01-2026

Joshua B Cohen sold 138,167 shares for a total transaction value of ~$1.9 million on Jan. 15 and Jan...

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?

Hedge Fund Boosts Stake in Amylyx Stock to $63 Million — Should Investors Follow?

7:00 09-12-2025

Austin-based Saturn V Capital Management added 1.3 million shares of Amylyx Pharmaceuticals in the t...

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

Amylyx Pharmaceuticals Announces New Safety and Tolerability Cohort 1 Data of AMX0114 in ALS from First-in-Human LUMINA Trial

9:00 05-12-2025

CAMBRIDGE, Mass.--(BUSINESS WIRE)---- $AMLX--Amylyx Pharmaceuticals Announces New Safety and Tolerab...

close

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

29-01-2026
SHAREHOLDERS SHOULD CONTACT THE FIRM IMMEDIATELY AS THERE MAY BE LIMITED TIME TO ENFORCE YOUR RIGHTS...
Více zde

AMYLYX PHARMACEUTICALS ANNOUNCES NOMINATION OF AMX0318 AS A NOVEL, LONG-ACTING GLP-1 RECEPTOR ANTAGONIST DEVELOPMENT CANDIDATE, IDENTIFIED IN COLLABORATION WITH GUBRA A/S

08-01-2026
CAMBRIDGE, MASS.--(BUSINESS WIRE)--AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) (“AMYLYX” OR THE ...
Více zde

AMYLYX PHARMACEUTICALS ANNOUNCES NEW SAFETY AND TOLERABILITY COHORT 1 DATA OF AMX0114 IN ALS FROM FIRST-IN-HUMAN LUMINA TRIAL

05-12-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS ANNOUNCES NEW SAFETY AND TOLERAB...
Více zde

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

28-11-2025
SHAREHOLDERS SHOULD CONTACT THE FIRM IMMEDIATELY AS THERE MAY BE LIMITED TIME TO ENFORCE YOUR RIGHTS...
Více zde

ROSEN LAW FIRM ANNOUNCES INVESTIGATION OF BREACHES OF FIDUCIARY DUTIES BY THE DIRECTORS AND OFFICERS OF AMYLYX PHARMACEUTICALS, INC. – AMLX

13-11-2025
NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGA...
Více zde

ROSEN LAW FIRM ANNOUNCES INVESTIGATION OF BREACHES OF FIDUCIARY DUTIES BY THE DIRECTORS AND OFFICERS OF AMYLYX PHARMACEUTICALS, INC. – AMLX

11-11-2025
NEW YORK--(BUSINESS WIRE)--ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES AN INVESTIGA...
Více zde

AMYLYX PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS

06-11-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)--AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) (“AMYLYX” OR THE ...
Více zde

NOTICE TO LONG-TERM SHAREHOLDERS OF AMYLYX PHARMACEUTICALS, INC. (AMLX): GRABAR LAW OFFICE IS INVESTIGATING CLAIMS ON YOUR BEHALF AS SECURITIES FRAUD CLASS ACTION SURVIVES MOTION TO DISMISS

04-11-2025
PHILADELPHIA, PENNSYLVANIA--(NEWSFILE CORP. - NOVEMBER 4, 2025) - GRABAR LAW OFFICE IS INVESTIGATING...
Více zde

HALPER SADEH LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

27-10-2025
NEW YORK--(BUSINESS WIRE)--HALPER SADEH LLC, AN INVESTOR RIGHTS LAW FIRM, IS INVESTIGATING WHETHER C...
Více zde

KUEHN LAW ENCOURAGES INVESTORS OF AMYLYX PHARMACEUTICALS, INC. TO CONTACT LAW FIRM

22-10-2025
NEW YORK , OCT. 22, 2025 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVE...
Více zde

AMYLYX INVESTIGATION: BRAGAR EAGEL & SQUIRE, P.C. URGES AMYLYX INVESTORS TO CONTACT THE FIRM REGARDING ONGOING INVESTIGATION INTO AMYLYX PHARMACEUTICALS, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS

16-10-2025
AMYLYX ALLEGEDLY MISLED INVESTORS ABOUT RELYVRIO'S DEMAND AND GROWTH, HIDING HIGH DISCONTINUATION RA...
Více zde

KUEHN LAW ENCOURAGES INVESTORS OF AMYLYX PHARMACEUTICALS, INC. TO CONTACT LAW FIRM

06-10-2025
NEW YORK , OCT. 6, 2025 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVES...
Více zde

AMYLYX PHARMACEUTICALS ANNOUNCES PRICING OF $175 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK

10-09-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) (“AMYLYX...
Více zde

AMYLYX PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK

09-09-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERI...
Více zde

AMYLYX PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

26-08-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS TO PARTICIPATE IN UPCOMING INVES...
Více zde

AMYLYX PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS

07-08-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINA...
Více zde

AMYLYX PHARMACEUTICALS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON AUGUST 7, 2025

31-07-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS TO REPORT SECOND QUARTER 2025 FI...
Více zde

AMYLYX ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING AMYLYX PHARMACEUTICALS, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

14-07-2025
BRAGAR EAGEL & SQUIRE, P.C. LITIGATION PARTNER  BRANDON WALKER  ENCOURAGES INVESTORS WHO SUFFERED ...
Více zde

AMYLYX PHARMACEUTICALS PRESENTS NEW EXPLORATORY ANALYSES FROM PHASE 2 AND PHASE 2B CLINICAL TRIALS OF AVEXITIDE IN POST-BARIATRIC HYPOGLYCEMIA AT ENDO 2025

13-07-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)--AMYLYX PHARMACEUTICALS, INC. (NASDAQ: AMLX) (“AMYLYX” OR THE ...
Více zde

AMYLYX PHARMACEUTICALS TO HOST EVENT TO DISCUSS POST-BARIATRIC HYPOGLYCEMIA AND AVEXITIDE AT ENDO 2025

08-07-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS TO HOST EVENT TO DISCUSS POST-BA...
Více zde

AMYLYX ALERT: BRAGAR EAGEL & SQUIRE, P.C. IS INVESTIGATING AMYLYX PHARMACEUTICALS, INC. ON BEHALF OF LONG-TERM STOCKHOLDERS AND ENCOURAGES INVESTORS TO CONTACT THE FIRM

07-07-2025
NEW YORK, JULY 07, 2025 (GLOBE NEWSWIRE) -- BRAGAR EAGEL & SQUIRE, P.C., A NATIONALLY RECOGNIZED SHA...
Více zde

AMYLYX PHARMACEUTICALS, INC. (AMLX) INVESTIGATION: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES STOCKHOLDERS TO CONTACT THE FIRM TO LEARN MORE ABOUT THE INVESTIGATION

17-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 17, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIG...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ANNOUNCES AN INVESTIGATION AGAINST AMYLYX PHARMACEUTICALS, INC. (AMLX) AND ENCOURAGES STOCKHOLDERS TO LEARN MORE ABOUT THE INVESTIGATION

15-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 15, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIG...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. (AMLX) INVESTORS TO INQUIRE ABOUT SECURITIES INVESTIGATION

12-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 12, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIG...
Více zde

KUEHN LAW ENCOURAGES INVESTORS OF AMYLYX PHARMACEUTICALS, INC. TO CONTACT LAW FIRM

11-06-2025
NEW YORK, JUNE 11, 2025 (GLOBE NEWSWIRE) -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS I...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC INITIATES AN INVESTIGATION INTO ALLEGATIONS AGAINST AMYLYX PHARMACEUTICALS, INC. (AMLX) AND ENCOURAGES INVESTORS TO REACH OUT

10-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 10, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIG...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ANNOUNCES AN INVESTIGATION AGAINST AMYLYX PHARMACEUTICALS, INC. (AMLX) AND ENCOURAGES SHAREHOLDERS TO LEARN MORE ABOUT THE INVESTIGATION

08-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 8, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

AMYLYX PHARMACEUTICALS, INC. (AMLX) INVESTIGATION: BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES INVESTORS TO CONTACT THE FIRM TO LEARN MORE ABOUT THE INVESTIGATION

05-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 5, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

BRONSTEIN, GEWIRTZ & GROSSMAN, LLC ENCOURAGES AMYLYX PHARMACEUTICALS, INC. (AMLX) SHAREHOLDERS TO INQUIRE ABOUT SECURITIES INVESTIGATION

03-06-2025
NEW YORK CITY, NY / ACCESS NEWSWIRE / JUNE 3, 2025 / BRONSTEIN, GEWIRTZ & GROSSMAN, LLC IS INVESTIGA...
Více zde

AMYLYX PHARMACEUTICALS RECEIVES U.S. FDA FAST TRACK DESIGNATION FOR AMX0114 FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

03-06-2025
CAMBRIDGE, MASS.--(BUSINESS WIRE)---- $AMLX--AMYLYX PHARMACEUTICALS RECEIVES U.S. FDA FAST TRACK DES...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-08 00:00:008-KStáhnout
2025-11-06 00:00:008-KStáhnout
2025-11-06 00:00:0010-QStáhnout
2025-09-10 01:00:008-KStáhnout
2025-09-10 00:00:008-KStáhnout
2025-08-27 01:00:008-KStáhnout
2025-08-27 00:00:008-KStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-06-05 01:00:008-KStáhnout
2025-06-05 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-03-04 00:00:008-KStáhnout
2025-03-04 00:00:0010-KStáhnout
2025-03-03 23:00:008-KStáhnout
2025-03-03 23:00:0010-KStáhnout
2025-01-10 00:00:008-KStáhnout
2025-01-09 23:00:008-KStáhnout
2024-12-30 00:00:008-KStáhnout
2024-12-29 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-10-17 01:00:008-KStáhnout
2024-10-17 00:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-07-10 01:00:008-KStáhnout
2024-07-10 00:00:008-KStáhnout
2024-06-21 01:00:008-KStáhnout
2024-06-21 00:00:008-KStáhnout
2024-06-06 01:00:008-KStáhnout
2024-06-06 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-04-10 01:00:008-KStáhnout
2024-04-10 00:00:008-KStáhnout
2024-04-04 01:00:008-KStáhnout
2024-04-04 00:00:008-KStáhnout
2024-03-14 00:00:008-KStáhnout
2024-03-13 23:00:008-KStáhnout
2024-03-08 00:00:008-KStáhnout
2024-03-07 23:00:008-KStáhnout
2024-02-22 00:00:008-KStáhnout
2024-02-22 00:00:0010-KStáhnout
2024-02-21 23:00:008-KStáhnout
2024-02-21 23:00:0010-KStáhnout
2023-12-07 00:00:008-KStáhnout
2023-12-06 23:00:008-KStáhnout
2023-11-09 00:00:008-KStáhnout
2023-11-09 00:00:0010-QStáhnout
2023-11-08 23:00:008-KStáhnout
2023-11-08 23:00:0010-QStáhnout
2023-10-13 01:00:008-KStáhnout
2023-10-13 00:00:008-KStáhnout
2023-08-10 01:00:008-KStáhnout
2023-08-10 01:00:0010-QStáhnout
2023-08-10 00:00:008-KStáhnout
2023-08-10 00:00:0010-QStáhnout
2023-07-26 01:00:008-KStáhnout
2023-07-26 00:00:008-KStáhnout
2023-06-23 01:00:008-KStáhnout
2023-06-23 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-05-11 01:00:008-KStáhnout
2023-05-11 01:00:0010-QStáhnout
2023-05-11 00:00:008-KStáhnout
2023-05-11 00:00:0010-QStáhnout
2023-03-21 00:00:008-KStáhnout
2023-03-20 23:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-13 00:00:0010-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-12 23:00:0010-KStáhnout
2023-02-14 00:00:008-KStáhnout
2023-02-13 23:00:008-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-11-10 00:00:008-KStáhnout
2022-11-10 00:00:0010-QStáhnout
2022-11-09 23:00:008-KStáhnout
2022-11-09 23:00:0010-QStáhnout
2022-11-02 00:00:008-KStáhnout
2022-11-01 23:00:008-KStáhnout
2022-09-30 01:00:008-KStáhnout
2022-09-30 00:00:008-KStáhnout
2022-08-11 01:00:008-KStáhnout
2022-08-11 01:00:0010-QStáhnout
2022-08-11 00:00:008-KStáhnout
2022-08-11 00:00:0010-QStáhnout
2022-07-05 01:00:008-KStáhnout
2022-07-05 00:00:008-KStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-06-09 01:00:008-KStáhnout
2022-06-09 00:00:008-KStáhnout
2022-06-03 01:00:008-KStáhnout
2022-06-03 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-03-31 01:00:008-KStáhnout
2022-03-31 01:00:0010-KStáhnout
2022-03-31 00:00:008-KStáhnout
2022-03-31 00:00:0010-KStáhnout
2022-01-11 00:00:008-KStáhnout
2022-01-10 23:00:008-KStáhnout
preloader